Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss
Mogrify Limited, a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, and Astellas Pharma Inc., a leader in regenerative medicine, today announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.
Deloitte appoints new senior partner for the South East region covering Cambridge, St Albans and Ipswich
Deloitte has appointed Fran Cousins as the new senior partner for the South East region - the first woman to hold this senior position in the region.
Guardtech Group support Ugandan COVID battle with CleanCube mobile lab donation
Suffolk-based cleanroom construction company gifts £50,000 laboratory van for critical PCR testing
Arecor announces presentation at EASD 2022 of Phase I clinical trial of AT278 ultra-concentrated ultra-rapid acting insulin for diabetes
Arecor Therapeutics plc, a globally focused biopharmaceutical company advancing today’s therapies to enable healthier lives, announces that its abstract titled “Phase I study investigating PK and PD of highly-concentrated insulin aspart AT278 U500” has been selected for presentation as part of the Short Oral Discussion Session A at the 58th Annual Meeting of the European Association for the Study…
Opportunities in China’s beauty value economy
What are the drivers for the phenomenal growth in China's hair care, anti-aging, and aesthetic medicine and cosmetic surgery markets?
eg technology renew sponsorship of 2022 EIT Health Catapult
eg technology are pleased to announce they have renewed their sponsorship of the coveted EIT Health Catapult, in association with EIT Health.
Change Management doesn’t change the one thing you most need to change
High Performance Change says: If you wanted to drive across Australia, you’d pack the vehicle with a survival kit – to help you adapt to any situation you might find yourself in – before you departed. It would be utter madness to even think about just setting off as if it were a normal trip, armed only with the idea of dealing with stuff as it happens along the way. And yet, if the only way you…
LG Chem renews license triggering payment to Avacta
LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme
Biocair expands its European network with a new Paris operational hub
Experts in logistics for the healthcare industry for more than 35 years, Biocair continues to expand in response to the growing demand from European players in the biotech and healthcare sectors.
Charity Shop Manager shares her story
Arthur Rank Hospice Charity Shop Manager, Billie, shares her personal story ahead of the Chariots of Fire Repay Race in Cambridge 2022
Avacta announces second dose escalation in the Phase I clinical study of AVA6000 Pro-doxorubicin
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces that the first-in-human Phase I trial (ALS-6000-101) of AVA6000 Pro-doxorubicin will advance to the third dose cohort following a positive review of the safety data from the dosing of the second cohort.
Bio-Rad launches EconoFit Chromatography Column Packs
HERCULES, Calif.— Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of EconoFit Low-Pressure Prepacked Chromatography Column Packs to support resin screening experiments in the development of protein purification workflows.
H.E.L Group releases iso-BTC+ calorimeter for isothermal battery performance testing
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, announces the release of iso-BTC+, the latest addition to its battery testing portfolio.
Bio-Rad introduces CFX Opus Deepwell Real-Time PCR Detection System
Hercules, Calif. — Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announces the launch of the CFX Opus Deepwell Real-Time PCR Detection System to support researchers in developing nucleic acid detection assays.
Ground-breaking digital approach helps cut pathology waiting times
An innovative partnership between East Kent Hospitals and digital pathology company Source LDPath, a part of SourceBio International plc, is helping to reduce pathology waiting times and improve patient care.
Retinal devices: how improved technical capability saved my sight
Head of Electronics Engineering at Team Consulting gives an account of how improved technical capability saved their sight.
Biocair develops dedicated team for cell and gene therapy logistics
Biocair has invested heavily in the creation of a specialist logistics team to meet the complex needs of the rapidly expanding cell and gene therapy sector.
6 methods for delivering drugs to the eye
The human eye is incredibly resilient. It has several physiological barriers to resist penetration of foreign molecules and particles, which makes drug delivery to the eye a real challenge.
FUJIFILM Irvine Scientific acquires exclusive license for artificial intelligence for IVF
Santa Ana, Calif., FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART), announces it has exclusively licensed the intellectual property relating to artificial intelligence (AI) for image-based evaluation of human embryos to improve in-vitro fertilization (IVF) success rates
Collaborating, creating and innovating with Guardtech’s revamped Design team
New Design Manager David Scholes reveals what the future holds for Suffolk firm’s freshly bolstered department.
Marion Jongkind joins Salus Wellness Clinics
We are very pleased to announce that Marion Jongkind has joined Salus Wellness this month.
Richard Withers joins Cambridge Healthcare Research as Strategic Advisor
The Board of Directors at Cambridge Healthcare Research (CHR) appoints Richard Withers as Strategic Advisor to support the business through it’s next period of growth.
Andrew Bell appointed Centre Manager at the EpiCentre, Haverhill
Andrew Bell has been appointed the new Centre Manager at the EpiCentre in Haverhill succeeding Kelly Boosey, and is excited to start his new role in the latter part of June.
Optibrium receives further investment from Kester Capital
Cambridge UK - Optibrium™, a developer of software for drug discovery, announces it has secured further investment from existing investors Kester Capital, a leading UK mid-market private equity firm.
Entries now open for the 2022 Deloitte UK Technology Fast 50 awards
Now in its 25th year, the awards recognise and rank the 50 fastest growing technology companies in the UK; Last year’s winner ClearBank achieved a three-year growth rate of 21,569% to the year 2020/21; The average three-year growth rate recorded for companies in the Deloitte UK Technology Fast 50 was 3,337% in 2020/21; Last year’s Fast 50 companies generated combined revenues of £2.92…